Deep learning designs abiotic miniproteins that improve antisense-oligonucleotide nuclear delivery
A generator–predictor–optimizer deep-learning workflow trained on quantitative delivery assays was used to design abiotic Mach miniproteins. Twelve selected predicted constructs were synthesized/tested; the strongest library construct improved phosphorodiamidate morpholino oligomer (PMO) delivery nearly 20-fold over unconjugated PMO in the standardized HeLa assay, while the authors describe the best designs as up to 50-fold more effective than prior polypeptide-based variants. PMO–Mach3/4 also produced dose-dependent reporter-protein restoration in skeletal muscle, diaphragm and heart in transgenic mice after a single intravenous dose.
Technology: Deep-learning generator–predictor–optimizer workflow: nested-LSTM sequence generator, CNN activity predictor on residue chemical fingerprints, and evolutionary optimization
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: A generator–predictor–optimizer deep-learning workflow trained on quantitative delivery assays was used to design abiotic Mach miniproteins.
- Still unknown: The paper reports improved delivery in a standardized HeLa reporter assay and transgenic mouse reporter model, not therapeutic correction of a disease. Only selected designs were synthesized (12 from hundreds of predicted sequences); mouse experiments used an EGFP reporter transgene and short seven-day follow-up. The article separately states the library's highest construct was nearly 20-fold over PMO alone and characterizes the designs as 50-fold better than previously known polypeptide variants; these denominators are not interchangeable. Safety evidence is limited to reported assays/doses and short follow-up.
- AI role: The model generated seed cell-penetrating sequences, predicted quantitative nuclear-delivery activity from peptide fingerprints, and iteratively optimized sequences for higher predicted activity subject to length, charge, similarity and solubility constraints. The team synthesized and experimentally assayed selected model-designed peptides; this linked the AI design to measured enhanced PMO delivery and animal reporter results.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8819921/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 86 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.